jenweiying

/jenweiying

About jenweiying

This author has not yet filled in any details.
So far jenweiying has created 4 blog entries.

ROCKET AF (2011): Rivaroxaban vs Warfarin in Atrial Fibrillation

2016-05-02T19:45:23+08:00 Anticoagulation, Atrial Fibrillation, Cardiology, Haematology, Haemostasis and Thrombosis, Novel Oral Anticoagulants|

Clinical question: in patients with atrial fibrillation, is rivaroxaban non-inferior to warfarin for the prevention of stroke or systemic embolism? Study design: multi-centre, randomized, double-blind, double-dummy, event-driven trial Inclusion criteria: Age ≥ 18 Non-valvular atrial fibrillation documented on ECG History of stroke, TIA or systemic embolism, or ≥ 2 of the following (i.e. CHADS2 ≥ 2) [...]

AFFIRM (2002): Rate versus Rhythm Control

2018-01-30T16:42:09+08:00 Atrial Fibrillation, Cardiology|

Clinical question: in patients at risk of stroke or death, what effect does rate or rhythm control of atrial fibrillation have on mortality? Study design: multi-centre, randomized, parallel group controlled trial Inclusion criteria: Age > 65 Patients with AF likely to be recurrent and result in illness or death, for which long-term treatment was warranted Presence [...]

BRIDGE (2015) – Peri-Procedural Bridging Anticoagulation

2016-04-24T17:47:39+08:00 Anticoagulation, Atrial Fibrillation, Cardiology, Haematology, Haemostasis and Thrombosis|

Clinical question: in patients with atrial fibrillation, is peri-operative heparin bridging required during interruption of warfarin therapy? Study design: randomized, double-blind placebo-controlled trial Inclusion criteria: Age ≥ 18 Permanent or paroxysmal atrial fibrillation / atrial flutter (confirmed by ECG / pacemaker interrogation), including valvular AF On warfarin for ≥ 3 months with a target INR of [...]

RE-LY (2009): Dabigatran versus Warfarin in Atrial Fibrillation

2016-04-24T17:47:46+08:00 Anticoagulation, Atrial Fibrillation, Cardiology, Haematology, Haemostasis and Thrombosis, Novel Oral Anticoagulants|

Clinical question: in patients with atrial fibrillation, is dabigatran non-inferior to warfarin for the prevention of stroke or systemic embolism? Study design: multinational randomized unblinded controlled trial comparing dabigatran with warfarin. Two doses of dabigatran (150mg BD and 110mg BD) also compared in a blinded fashion. Inclusion criteria: Documented atrial fibrillation on ECG Age > 18 [...]

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.